Merlin C. Thomas

发表

Central Australia Renal Study: Technical Report and Technical Appendices

Alan Cass, A. D. Brown, Samantha J. Togni, 2011 .

Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes

Merlin C. Thomas, Richard J. MacIsaac, R. MacIsaac, 2011, Diabetes Care.

Anemia in diabetes: marker or mediator of microvascular disease?

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2007, Nature Clinical Practice Nephrology.

The epidemiology of hemoglobin levels in patients with type 2 diabetes.

Merlin C. Thomas, R. MacIsaac, C. Tsalamandris, 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The high prevalence of anemia in diabetes is linked to functional erythropoietin deficiency.

Merlin C. Thomas, M. Thomas, 2006, Seminars in nephrology.

Diastolic dysfunction is associated with anaemia in patients with Type II diabetes.

Merlin C. Thomas, R. MacIsaac, G. Jerums, 2006, Clinical science.

Anemia in patients with type 1 diabetes.

Merlin C. Thomas, R. MacIsaac, C. Tsalamandris, 2004, The Journal of clinical endocrinology and metabolism.

The burden of anaemia in type 2 diabetes and the role of nephropathy: a cross-sectional audit.

Merlin C. Thomas, R. MacIsaac, C. Tsalamandris, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Unrecognized anemia in patients with diabetes: a cross-sectional survey.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2003, Diabetes care.

Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells

Merlin C. Thomas, M. Cooper, A. El-Osta, 2012, Circulation research.

Diabetic kidney disease

Merlin C. Thomas, P. Groop, M. Cooper, 2015, Nature Reviews Disease Primers.

Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008, American journal of physiology. Endocrinology and metabolism.

Nutrient Sensing, Autophagy, and Diabetic Nephropathy

Merlin C. Thomas, S. Kume, D. Koya, 2011, Diabetes.

Diabetic kidney disease

Merlin C. Thomas, P. Groop, Merlin C Thomas, 2015, Nature Reviews Disease Primers.

Connective tissue growth factor plays an important role in advanced glycation end product-induced tubular epithelial-to-mesenchymal transition: implications for diabetic renal disease.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2006, Journal of the American Society of Nephrology : JASN.

Advanced glycation end products and diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2005, American journal of therapeutics.

Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension

Merlin C. Thomas, C. Forsblom, P. Groop, 2010, Annals of medicine.

miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression

Merlin C. Thomas, M. Cooper, W. Burns, 2010, Diabetes.

Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Merlin C. Thomas, Merlin C Thomas, D. Liew, 2016, Current cardiology reviews.

Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis

Merlin C. Thomas, A. Murphy, E. Fisher, 2020, Circulation research.

The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology

Merlin C. Thomas, Merlin C Thomas, W. Burns, 2010, Expert Reviews in Molecular Medicine.

The Role of Tubular Epithelial-Mesenchymal Transition in Progressive Kidney Disease

Merlin C. Thomas, W. Burns, P. Kantharidis, 2007, Cells Tissues Organs.

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Merlin C. Thomas, C. Tikellis, M. Thomas, 2012, International journal of peptides.

Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications

Merlin C. Thomas, D. Gordin, C. Forsblom, 2012, Journal of hypertension.

Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease

Merlin C. Thomas, P. Zimmet, M. Cooper, 2016, Nature Reviews Nephrology.

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2008, The Journal of clinical endocrinology and metabolism.

Specific management of IgA nephropathy: role of fish oil

Merlin C. Thomas, Merlin C Thomas, 2006 .

Prevention of Progression of Kidney Disease

Merlin C. Thomas, David W. Johnson, D. Harris, 2006 .

A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2012, Expert opinion on drug metabolism & toxicology.

The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes

Merlin C. Thomas, C. Forsblom, P. Groop, 2009, Diabetes.

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

Merlin C. Thomas, M. Cooper, P. Kantharidis, 2014, Kidney international.

Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis

Merlin C. Thomas, Merlin C Thomas, J. Golledge, 2018, The Journal of clinical investigation.

Metabolic Karma—The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture

Merlin C. Thomas, M. Cooper, A. El-Osta, 2018, Diabetes.

Dicarbonyl Stress in the Absence of Hyperglycemia Increases Endothelial Inflammation and Atherogenesis Similar to That Observed in Diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2014, Diabetes.

Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.

Merlin C. Thomas, A. Murphy, Merlin C Thomas, 2014, Clinical science.

Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse

Merlin C. Thomas, F. Rosenfeldt, M. Cooper, 2010, Diabetes.

Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008, Diabetes.

Can you reduce your AGE?: Strategies to prevent AGE accumulation in diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2007 .

Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?

Merlin C. Thomas, J. Forbes, G. Soldatos, 2005, The Clinical biochemist. Reviews.

Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, G. Jerums, 2005, Journal of the American Society of Nephrology : JASN.

Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2004, Diabetes.

Absence of RAGE protects from atherosclerosis in diabetes RAGE DEFICIENCY ATTENUATES THE DEVELOPMENT OF ATHEROSCLEROSIS IN DIABETES

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2008 .

The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes.

Merlin C. Thomas, M. Cooper, M. Coughlan, 2023, Cell metabolism.

Nonalbuminuric Renal Impairment in Type 2 Diabetic Patients and in the General Population (National Evaluation of the Frequency of Renal Impairment cO-existing with NIDDM [NEFRON] 11)

Merlin C. Thomas, J. Shaw, R. Atkins, 2009, Diabetes Care.

Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.

Merlin C. Thomas, M. Cooper, C. Tikellis, 2006, The international journal of biochemistry & cell biology.

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, G. Jerums, 2002, Diabetes.

Deficiency in Apoptosis-Inducing Factor Recapitulates Chronic Kidney Disease via Aberrant Mitochondrial Homeostasis

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2016, Diabetes.

Imbalance of the renin–angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Peter R Gibson, Chin Wee Tan, Merlin C. Thomas, 2019, Gut.

A Breaker of Advanced Glycation End Products Attenuates Diabetes‐Induced Myocardial Structural Changes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2003, Circulation research.

Direct antiatherosclerotic effects of PPAR agonists

Merlin C. Thomas, C. Tikellis, A. Calkin, 2009, Current opinion in lipidology.

Renal effects of cyclo‐oxygenase‐2 inhibition

Merlin C. Thomas, D. Harris, Merlin C Thomas, 2002 .

PPAR Agonists and Cardiovascular Disease in Diabetes

Merlin C. Thomas, A. Calkin, M. Thomas, 2008, PPAR research.

Pre‐dialysis education for patients with chronic kidney disease

Merlin C. Thomas, Merlin C Thomas, 2007 .

Early referral of patients with pre‐end‐stage kidney disease

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2007 .

Tubular changes in early diabetic nephropathy.

Merlin C. Thomas, M. Cooper, W. Burns, 2005, Advances in chronic kidney disease.

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis.

Merlin C. Thomas, M. Cooper, R. Komers, 2012, Journal of the American Society of Nephrology : JASN.

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.

Merlin C. Thomas, B. Brenner, H. Parving, 2011, Kidney international.

High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment.

Merlin C. Thomas, Merlin C Thomas, K. Denton, 2010, American journal of physiology. Renal physiology.

Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes

Merlin C. Thomas, P. Secchiero, G. Zauli, 2014, Molecular and Cellular Endocrinology.

Merlin C. Thomas, M. Cooper, P. Secchiero, 2012, Clinical science.

Membranous nephropathy: role of steroids

Merlin C. Thomas, Merlin C Thomas, 2006 .

Role of advanced glycation end products in diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2003, Journal of the American Society of Nephrology : JASN.

Contextualizing Genetics for Regional Heart Failure Care

Merlin C. Thomas, D. Fatkin, D. Hare, 2016, Current cardiology reviews.

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial

Merlin C. Thomas, M. Woodward, Merlin C Thomas, 2018, Journal of the American Heart Association.

Do we need a Wider Therapeutic Paradigm for Heart Failure with Comorbidities? - A Remote Australian Perspective

Merlin C. Thomas, A. Brown, D. Hare, 2016 .

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

Merlin C. Thomas, Marja-Riitta Taskinen, Carol Forsblom, 2005, Diabetes care.

High-salt diet increases glomerular ACE/ACE2 ratio leading to oxidative stress and kidney damage.

Merlin C. Thomas, C. Johnston, Merlin C Thomas, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study.

Merlin C. Thomas, G. Russ, T. Mathew, 2001, Transplantation.

Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes

Merlin C. Thomas, G. Russ, T. Mathew, 2000, BMC nephrology.

The CARI guidelines. Prevention of progression of kidney disease.

Merlin C. Thomas, David W. Johnson, Merlin C Thomas, 2006, Nephrology.

Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes

Merlin C. Thomas, C. Forsblom, P. Groop, 2018, Diabetes, obesity & metabolism.

Post-translational modification of plant-made foreign proteins; glycosylation and beyond.

Merlin C. Thomas, Merlin C Thomas, Diane E Webster, 2012, Biotechnology advances.

Severe acute respiratory syndrome coronavirus 2 as a potential cause of type 1 diabetes facilitated by spike protein receptor binding domain attachment to human islet cells: An illustrative case study and experimental data

Merlin C. Thomas, D. O'Neal, Merlin C Thomas, 2021, Diabetic medicine : a journal of the British Diabetic Association.

Non-invasive Risk Stratification for Coronary Artery Disease: Is It Time for Subclassifications?

Merlin C. Thomas, W. Chan, S. Noaman, 2019, Current Cardiology Reports.

Mechanisms of Disease: pathway-selective insulin resistance and microvascular complications of diabetes

Merlin C. Thomas, Carol Forsblom, Per-Henrik Groop, 2005, Nature Clinical Practice Endocrinology &Metabolism.

Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop.

Merlin C. Thomas, Merlin C Thomas, G. Zauli, 2011, Atherosclerosis.

Preventing diabetes in patients with hypertension: one more reason to block the renin–angiotensin system

Merlin C. Thomas, M. Cooper, C. Tikellis, 2006, Journal of Hypertension - Supplement.

Improved islet morphology after blockade of the renin- angiotensin system in the ZDF rat.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2004, Diabetes.

Pyridoxamine prevents increased atherosclerosis by intermittent methylglyoxal spikes in the aortic arches of ApoE-/- mice.

Merlin C. Thomas, A. Murphy, M. Cooper, 2023, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice.

Merlin C. Thomas, M. Cooper, A. Bierhaus, 2014, Atherosclerosis.

Alagebrium Reduces Glomerular Fibrogenesis and Inflammation Beyond Preventing RAGE Activation in Diabetic Apolipoprotein E Knockout Mice

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2012, Diabetes.

Interactions between renin angiotensin system and advanced glycation in the kidney.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2005, Journal of the American Society of Nephrology : JASN.

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2004, Kidney international.

Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2011, Diabetes.

Relationship Between Urinary Sodium Excretion Over Time and Mortality in Type 2 Diabetes

Merlin C. Thomas, John L Moran, Merlin C Thomas, 2014, Diabetes Care.

Perspective Review: Type 2 Diabetes and Readmission for Heart Failure

Merlin C. Thomas, M. Thomas, 2018, Clinical Medicine Insights. Cardiology.

Case 27. A Modicum Of Suspicion: Diabetic Kidney Disease And Dyslipidemia

Merlin C. Thomas, P. Groop, 2006 .

ACE2 deficiency shifts energy metabolism towards glucose utilization.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2015, Metabolism: clinical and experimental.

Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes

Merlin C. Thomas, R. Ma, T. Hansen, 2023, The Journal of clinical investigation.

Problems and advantages of continuous renal replacement therapy *

Merlin C. Thomas, D. Harris, Merlin C Thomas, 2002 .

Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2012, Clinical science.

Anemia with impaired erythropoietin response in diabetic patients.

Merlin C. Thomas, R. MacIsaac, C. Tsalamandris, 2005, Archives of internal medicine.

Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Merlin C. Thomas, B. Kasiske, A. Levin, 2016, Kidney international.

Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2008, Clinical science.

Diuretics, ACE inhibitors and NSAIDs — the triple whammy

Merlin C. Thomas, M. Thomas, 2000, The Medical journal of Australia.

Increased thrombotic vascular events after change of statin

Merlin C. Thomas, Merlin C Thomas, J. Mann, 1998, The Lancet.

Serum lipids and the progression of nephropathy in type 1 diabetes.

Merlin C. Thomas, M. Taskinen, C. Forsblom, 2006, Diabetes care.

The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, American journal of physiology. Renal physiology.

Inherited susceptibility to diabetic nephropathy

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2003 .

Epigenetic Mechanisms in Diabetic Kidney Disease

Merlin C. Thomas, M. Thomas, 2016, Current Diabetes Reports.

Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan

Merlin C. Thomas, J. Shaw, A. D. De Livera, 2020, Trials.

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status

Merlin C. Thomas, Merlin C Thomas, P. Gibson, 2019, Therapeutic advances in gastroenterology.

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Merlin C. Thomas, D. Gordin, C. Forsblom, 2011, Journal of the American Society of Nephrology : JASN.

The potential and pitfalls of GLP-1 receptor agonists for renal protection in type 2 diabetes.

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2017, Diabetes & metabolism.

Type 2 Diabetes and Heart Failure: Challenges and Solutions

Merlin C. Thomas, M. Thomas, 2016, Current cardiology reviews.

Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, Circulation research.

Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?

Merlin C. Thomas, Merlin C Thomas, P. Iyngkaran, 2019, Current cardiology reviews.

Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.

Merlin C. Thomas, Merlin C Thomas, P. Little, 2005, Kidney international.

Targeting the Pathobiology of Diabetic Kidney Disease

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2021, Advances in Chronic Kidney Disease.

Anaemia in diabetes: an emerging complication of microvascular disease.

Merlin C. Thomas, R. MacIsaac, C. Tsalamandris, 2005, Current diabetes reviews.

Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, Journal of hypertension.

Genetic deletion of cell division autoantigen 1 retards diabetes-associated renal injury.

Merlin C. Thomas, M. Cooper, Jiaze Li, 2013, Journal of the American Society of Nephrology : JASN.

Targets to retard the progression of diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2005, Kidney international.

Towards understanding the inherited susceptibility for nephropathy in diabetes

Merlin C. Thomas, P. Groop, Merlin C Thomas, 2012, Current opinion in nephrology and hypertension.

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

Merlin C. Thomas, T. Walther, M. Cooper, 2010, Diabetologia.

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2004, Journal of the American Society of Nephrology : JASN.

AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2015, Hypertension.

Added Value of Soluble Tumor Necrosis Factor-α Receptor 1 as a Biomarker of ESRD Risk in Patients With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2014, Diabetes Care.

Cellular Biology Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2012 .

Does a Nephron Deficit Exacerbate the Renal and Cardiovascular Effects of Obesity?

Merlin C. Thomas, Merlin C Thomas, Russell D. Brown, 2013, PloS one.

High nephron endowment protects against salt-induced hypertension.

Merlin C. Thomas, Merlin C Thomas, J. Bertram, 2012, American journal of physiology. Renal physiology.

Early detection of patients with kidney disease

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2007 .

The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes.

Merlin C. Thomas, N. Anavekar, N. Anavekar, 2013, Diabetes & metabolism.

Activation of the Renin-Angiotensin System Mediates the Effects of Dietary Salt Intake on Atherogenesis in the Apolipoprotein E Knockout Mouse

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2012, Hypertension.

Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

Merlin C. Thomas, M. Woodward, G. Hillis, 2015, Diabetes Care.

Emerging drugs for managing kidney disease in patients with diabetes

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2013, Expert opinion on emerging drugs.

New approaches to the treatment of nephropathy in diabetes

Merlin C. Thomas, P. Groop, M. Thomas, 2011, Expert opinion on investigational drugs.

Blockade of the renin–angiotensin system for the primary prevention of diabetic nephropathy

Merlin C. Thomas, Merlin C Thomas, R. Macginley, 2012 .

Interactions between growth factors in the kidney: implications for progressive renal injury.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2003, Kidney international.

Osteopontin Is a Strong Predictor of Incipient Diabetic Nephropathy, Cardiovascular Disease, and All-Cause Mortality in Patients With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2014, Diabetes Care.

The arterial depressor response to chronic low-dose angiotensin II infusion in female rats is estrogen dependent.

Merlin C. Thomas, Merlin C Thomas, C. Tikellis, 2012, American journal of physiology. Regulatory, integrative and comparative physiology.

Interactions between renin angiotensin system and advanced glycation in the kidney.

Merlin C. Thomas, J. Forbes, C. Tikellis, 2005, Journal of the American Society of Nephrology : JASN.

Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).

Merlin C. Thomas, C. Johnston, Merlin C Thomas, 2012, Clinical science.

ACE2 Deficiency Modifies Renoprotection Afforded by ACE Inhibition in Experimental Diabetes

Merlin C. Thomas, C. Johnston, Merlin C Thomas, 2008, Diabetes.

PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2006 .

High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2005, Journal of molecular endocrinology.

Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

Merlin C. Thomas, C. Johnston, M. Cooper, 2006, Kidney international.

Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice

Merlin C. Thomas, Merlin C Thomas, J. Horowitz, 2020, Current cardiology reviews.

Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2010, American journal of physiology. Renal physiology.

Dicarbonyl-mediated AGEing and diabetic kidney disease

Merlin C. Thomas, Carlos J. Rosado, A. Dimitropoulos, 2020, Journal of Nephrology.

Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2004, Current pharmaceutical design.

Bedside–to-Bench Translational Research for Chronic Heart Failure: Creating an Agenda for Clients Who Do Not Meet Trial Enrollment Criteria

Merlin C. Thomas, P. Iyngkaran, M. Thomas, 2015, Clinical Medicine Insights. Cardiology.

Targeted reduction of advanced glycation improves renal function in obesity.

Merlin C. Thomas, M. Cooper, B. Kingwell, 2011, Kidney international.

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2010, Kidney international.

RAGE Deletion Confers Renoprotection by Reducing Responsiveness to Transforming Growth Factor-β and Increasing Resistance to Apoptosis

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2018, Diabetes.

Candesartan Attenuates Diabetic Retinal Vascular Pathology by Restoring Glyoxalase-I Function

Merlin C. Thomas, M. Cooper, R. Nagaraj, 2010, Diabetes.

Prevention of Progression of Kidney Disease

Merlin C. Thomas, David W. Johnson, D. Harris, 2006 .

Pathogenesis and progression of proteinuria.

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2011, Contributions to nephrology.

Serum adiponectin concentration is a positive predictor of all‐cause and cardiovascular mortality in type 1 diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2011, Journal of internal medicine.

Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes.

Merlin C. Thomas, D. Gordin, C. Forsblom, 2013, Clinical science.

Autosomal‐dominant polycystic kidney disease

Merlin C. Thomas, M. Thomas, 2007 .

Investigating structural and biochemical correlates of ganglion cell dysfunction in streptozotocin-induced diabetic rats.

Christine T. O. Nguyen, Zheng He, Mary Tolcos, 2009, Experimental eye research.

The long-term incidence of hospitalization for ketoacidosis in adults with established T1D - a prospective cohort study.

Merlin C. Thomas, D. Gordin, C. Forsblom, 2019, The Journal of clinical endocrinology and metabolism.

Advanced glycation end products.

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2011, Contributions to nephrology.

Pathogenetic Mechanisms of Diabetic Nephropathy

Merlin C. Thomas, Merlin C Thomas, M. Thomas, 2011 .

A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart Failure

Merlin C. Thomas, Merlin C Thomas, J. Horowitz, 2016, Clinical Medicine Insights. Cardiology.

Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysis.

Merlin C. Thomas, Merlin C Thomas, D. Power, 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.

Merlin C. Thomas, Merlin C Thomas, R. MacIsaac, 2005, Kidney international.

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Merlin C. Thomas, M. Cooper, B. Feng, 2009, Diabetologia.

The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology

Merlin C. Thomas, W. Burns, Wendy C. Burns, 2010, Expert Reviews in Molecular Medicine.

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.

Merlin C. Thomas, B. Brenner, H. Parving, 2011, Kidney international.

Identification of angiotensin converting enzyme 2 in the rodent retina

Merlin C. Thomas, C. Johnston, M. Cooper, 2004, Current eye research.

Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2

Merlin C. Thomas, Merlin C Thomas, J. Golledge, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Excess Mortality in Patients With Type 1 Diabetes Without Albuminuria—Separating the Contribution of Early and Late Risks

Merlin C. Thomas, C. Forsblom, P. Groop, 2018, Diabetes Care.

Comorbid Heart Failure and Renal Impairment: Epidemiology and Management

Merlin C. Thomas, C. Ronco, Merlin C Thomas, 2012, Cardiorenal Medicine.

Glycemic exposure, glycemic control, and metabolic karma in diabetic complications.

Merlin C. Thomas, M. Thomas, 2014, Advances in chronic kidney disease.

Heart Failure in Minority Populations - Impediments to Optimal Treatment in Australian Aborigines

Merlin C. Thomas, Merlin C Thomas, J. Atherton, 2016, Current cardiology reviews.

Preventing Progression of Chronic Kidney Disease: Diet and Lifestyle

Merlin C. Thomas, M. Thomas, 2014 .

The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2011, Diabetes Care.

Low testosterone levels are common and associated with insulin resistance in men with diabetes.

Merlin C. Thomas, R. MacIsaac, G. Jerums, 2008, The Journal of clinical endocrinology and metabolism.

SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates

Merlin C. Thomas, K. Rogers, D. Purcell, 2023, Proceedings of the National Academy of Sciences of the United States of America.

The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure

Merlin C. Thomas, D. Cherney, 2018, Diabetologia.

MK-767. Kyorin/Banyu/Merck.

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2003, Current opinion in investigational drugs.

Angiotensin converting enzyme 2 and atherosclerosis.

Merlin C. Thomas, Merlin C Thomas, J. Golledge, 2013, Atherosclerosis.

Management of patients with diabetes and CKD

Merlin C. Thomas, B. Kasiske, A. Levin, 2022 .

Screening for chronic kidney disease in patients with diabetes: are we missing the point?

Merlin C. Thomas, P. Groop, Merlin C Thomas, 2008, Nature Clinical Practice Nephrology.

The Role of Advanced Glycation in Reduced Organic Cation Transport Associated with Experimental Diabetes

Merlin C. Thomas, Merlin C Thomas, M. Cooper, 2004, Journal of Pharmacology and Experimental Therapeutics.

Reduced tubular cation transport in diabetes: prevented by ACE inhibition.

Merlin C. Thomas, Merlin C Thomas, G. Jerums, 2003, Kidney international.

Prevention of Progression of Kidney Disease

Merlin C. Thomas, David W. Johnson, D. Harris, 2006 .

Blood Pressure Lowering for the Prevention and Treatment of Diabetic Kidney Disease

Merlin C. Thomas, R. Atkins, Merlin C Thomas, 2012, Drugs.

The role and management of sympathetic overactivity in cardiovascular and renal complications of diabetes.

Merlin C. Thomas, N. Anavekar, P. Iyngkaran, 2013, Diabetes & metabolism.

Diabetes: Assessing renal risk in patients with type 2 diabetes

Merlin C. Thomas, P. Groop, M. Thomas, 2013, Nature Reviews Nephrology.

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

Merlin C. Thomas, M. Taskinen, C. Forsblom, 2005, Diabetes care.

Dietary intake and hospitalisation due to diabetic ketoacidosis and hypoglycaemia in individuals with type 1 diabetes

Merlin C. Thomas, C. Forsblom, P. Groop, 2021, Scientific Reports.

Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes

Merlin C. Thomas, D. Gordin, C. Forsblom, 2013, Diabetes Care.

Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))

Merlin C. Thomas, Merlin C Thomas, G. Jerums, 2002 .

Erratum: ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes (Diabetes (2008) 57 (1018-1025))

Merlin C. Thomas, C. Johnston, J. Pete, 2011 .